Zobrazeno 1 - 10
of 108
pro vyhledávání: '"MEHA SHARMA"'
Autor:
Deep Dutta, Lakshmi Nagendra, BG Harish, Meha Sharma, Ameya Joshi, Basavanagowdappa Hathur, ABM Kamrul-Hasan
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 28, Iss 5, Pp 436-444 (2024)
No meta-analysis has analysed role of cagrilintide as weight-loss medication in obese individuals. Electronic databases were searched for RCTs involving obese individuals receiving cagrilintide or cagrilintide-2.4 mg with semaglutide-2.4 mg combinati
Externí odkaz:
https://doaj.org/article/753aab80fda54b3892b6778502bcad4e
Publikováno v:
Indian Heart Journal, Vol 76, Iss 5, Pp 333-341 (2024)
Background: Gender differences in acute coronary syndrome (ACS) outcomes have been noted in global data, which however did not analyse Indian data. No prior systematic review and meta-analysis (SRM) has addressed this important aspect of gender bias
Externí odkaz:
https://doaj.org/article/d23cec2cfd3b4bf5a120bdd76fbf4b91
Autor:
Lakshmi Nagendra, Deep Dutta, Harish Bukkasagar Girijashankar, Deepak Khandelwal, Tejal Lathia, Meha Sharma
Publikováno v:
Annals of Pediatric Endocrinology & Metabolism, Vol 29, Iss 2, Pp 82-89 (2024)
Purpose Sodium glucose cotransporter-2 inhibitors (SGLT2i) have been evaluated in children with type 2 diabetes mellitus (T2DM), type 1 diabetes mellitus (T1DM), and several other nondiabetic conditions. Potential tolerability issues have prevented t
Externí odkaz:
https://doaj.org/article/b59ccbb762e149c893c9cd8bd3d178b2
Publikováno v:
Obesity Science & Practice, Vol 10, Iss 2, Pp n/a-n/a (2024)
Abstract Background Orforglipron is a novel once‐daily oral non‐peptide glucagon‐like peptide‐1 receptor agonist with several recently published randomized controlled trials (RCTs) evaluating its role in diabetes and obesity. No meta‐analys
Externí odkaz:
https://doaj.org/article/f764895571a54ee68517649233331dff
Autor:
Meha Sharma, Satish Suhas
Publikováno v:
Journal of Psychiatry Spectrum, Vol 2, Iss 2, Pp 133-136 (2023)
Externí odkaz:
https://doaj.org/article/14dc90c0faf2457485ec42a625765fc1
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 27, Iss 6, Pp 467-475 (2023)
Background: Mechanistically, subcutaneous ultra-rapid lispro (URLi) is faster than lispro. Whether this translates into a better post-prandial glucose (PPG) and glycemic control in type-1 diabetes (T1DM) and type-2 diabetes (T2DM) is unclear. Hence,
Externí odkaz:
https://doaj.org/article/855a8728a60b4e3eb986a18d6e9ae489
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 27, Iss 5, Pp 377-386 (2023)
Background: Polyethylene glycol loxenatide (peg-loxenatide) is a novel glucagon-like peptide-1 receptor agonist developed and available for clinical use in China. This meta-analysis was performed as no meta-analysis has analysed the efficacy and safe
Externí odkaz:
https://doaj.org/article/be555b1578124f47b6102713e2a728a6
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 27, Iss 3, Pp 192-200 (2023)
Meta-analysis studying the role of verapamil in improving C-peptide in people with recent-onset type-1 diabetes (T1DM) has not been conducted to date. We undertook this meta-analysis to address this knowledge gap. Electronic databases were systematic
Externí odkaz:
https://doaj.org/article/16bee36674ca461da315d1c2723c0515
Publikováno v:
Diabetes & Metabolism Journal, Vol 47, Iss 1, Pp 72-81 (2023)
Background No meta-analysis has analysed efficacy and safety of fast-acting aspart insulin (FIAsp) with insulin pump in type 1 diabetes mellitus (T1DM). Methods Electronic databases were searched for randomised controlled trials (RCTs) involving T1DM
Externí odkaz:
https://doaj.org/article/ef831188a1f6403aba312bdd6e449fa4
Publikováno v:
JCRPE, Vol 14, Iss 2, Pp 131-144 (2022)
No meta-analysis is available which has analysed the role of letrozole in constitutional delay in growth and puberty (CDGP). Electronic databases were searched for randomized controlled trials (RCTs) involving children with CDGP receiving letrozole.
Externí odkaz:
https://doaj.org/article/d36c4a6c9e684fe0b560021c441c5071